Women’s health and diagnostics company Hologic is selling its line of medical aesthetics products for $205 million, two years after purchasing them for more than $1 billion.

The Marlborough, Massachusetts-based technology company first announced plans to unload Cynosure in November, and completed the deal on Dec. 30. In an announcement, President and CEO Steve MacMillan said the divestiture will allow Hologic to focus on its core products, which include mammography systems and other breast imaging solutions.

Read the full article at radiologybusiness.com